Grifols SA (GRFS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $7.64, +1.33% vs the prior close of $7.54.
- Volume 872.36K shares, 1.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GRFS rises 1.3% to $7.64, a 1-month high, 3 up days in a row. Closed at $7.64, +1.33% vs the prior close of $7.54. Day range $7.57–$7.75, opened at $7.59.
GRFS daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — GRFS rises 1.3% to $7.64, a 1-month high, 3 up days in a row
- Closed at $7.64, +1.33% vs the prior close of $7.54. Day range $7.57–$7.75, opened at $7.59.
- Volume was 872.36K shares, 1.8x its 50-day average of 492.29K.
- Price is +0.3% vs its 50-day average ($7.62) and -5.4% vs its 200-day average ($8.07).
- 52-week range $6.96–$9.90; today's close sits at 23% of that range, 22.8% below the 52-week high.
- That makes 3 straight gains.
Oct 15, 2026 — GRFS jumps 4.1% to $7.54, a 1-month high on 1.9x normal volume
- Closed at $7.54, +4.14% vs the prior close of $7.24. Day range $7.40–$7.56, opened at $7.51.
- Volume was 907.10K shares, 1.9x its 50-day average of 483.00K — unusually heavy trading.
- Price is -1.1% vs its 50-day average ($7.62) and -6.7% vs its 200-day average ($8.08).
- 52-week range $6.96–$9.90; today's close sits at 20% of that range, 23.8% below the 52-week high.
Oct 14, 2026 — GRFS rises 1.0% to $7.24
- Closed at $7.24, +0.98% vs the prior close of $7.17. Day range $7.22–$7.40, opened at $7.29.
- Volume was 538.50K shares, 1.1x its 50-day average of 484.89K.
- Price is -5.1% vs its 50-day average ($7.63) and -10.5% vs its 200-day average ($8.09).
- 52-week range $6.96–$9.90; today's close sits at 10% of that range, 26.9% below the 52-week high.
Oct 13, 2026 — GRFS dips 2.7% to $7.17, a 3-month low
- Closed at $7.17, -2.71% vs the prior close of $7.37. Day range $7.15–$7.36, opened at $7.36.
- Volume was 439.50K shares, 0.9x its 50-day average of 483.56K.
- Price is -6.2% vs its 50-day average ($7.65) and -11.4% vs its 200-day average ($8.10).
- 52-week range $6.96–$9.90; today's close sits at 7% of that range, 27.6% below the 52-week high.
Oct 12, 2026 — GRFS dips 1.2% to $7.37
- Closed at $7.37, -1.21% vs the prior close of $7.46. Day range $7.36–$7.52, opened at $7.52.
- Volume was 266.10K shares, 0.5x its 50-day average of 487.94K — lighter than usual.
- Price is -3.8% vs its 50-day average ($7.66) and -9.1% vs its 200-day average ($8.11).
- 52-week range $6.96–$9.90; today's close sits at 14% of that range, 25.6% below the 52-week high.
Oct 9, 2026 — GRFS rises 0.7% to $7.46
- Closed at $7.46, +0.67% vs the prior close of $7.41. Day range $7.44–$7.53, opened at $7.51.
- Volume was 330.60K shares, 0.7x its 50-day average of 503.88K.
- Price is -2.8% vs its 50-day average ($7.67) and -8.1% vs its 200-day average ($8.11).
- 52-week range $6.96–$9.90; today's close sits at 17% of that range, 24.6% below the 52-week high.
Oct 8, 2026 — GRFS dips 1.2% to $7.41
- Closed at $7.41, -1.20% vs the prior close of $7.50. Day range $7.28–$7.45, opened at $7.42.
- Volume was 368.10K shares, 0.7x its 50-day average of 534.59K.
- Price is -3.6% vs its 50-day average ($7.69) and -8.8% vs its 200-day average ($8.12).
- 52-week range $6.96–$9.90; today's close sits at 15% of that range, 25.2% below the 52-week high.
Oct 7, 2026 — GRFS ends flat (-0.3%) to $7.50
- Closed at $7.50, -0.27% vs the prior close of $7.52. Day range $7.44–$7.56, opened at $7.48.
- Volume was 260.70K shares, 0.5x its 50-day average of 554.63K — lighter than usual.
- Price is -2.6% vs its 50-day average ($7.70) and -7.8% vs its 200-day average ($8.13).
- 52-week range $6.96–$9.90; today's close sits at 18% of that range, 24.2% below the 52-week high.
Oct 6, 2026 — GRFS rises 1.5% to $7.52, 3 up days in a row
- Closed at $7.52, +1.48% vs the prior close of $7.41. Day range $7.42–$7.57, opened at $7.53.
- Volume was 326.10K shares, 0.6x its 50-day average of 555.89K — lighter than usual.
- Price is -2.5% vs its 50-day average ($7.71) and -7.6% vs its 200-day average ($8.14).
- 52-week range $6.96–$9.90; today's close sits at 19% of that range, 24.0% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — GRFS rises 1.4% to $7.41
- Closed at $7.41, +1.37% vs the prior close of $7.31. Day range $7.29–$7.54, opened at $7.31.
- Volume was 492.80K shares, 0.8x its 50-day average of 607.88K.
- Price is -4.0% vs its 50-day average ($7.72) and -9.0% vs its 200-day average ($8.15).
- 52-week range $6.96–$10.16; today's close sits at 14% of that range, 27.1% below the 52-week high.
Oct 2, 2026 — GRFS ends flat (+0.1%) to $7.31
- Closed at $7.31, +0.14% vs the prior close of $7.30. Day range $7.24–$7.36, opened at $7.30.
- Volume was 390.40K shares, 0.6x its 50-day average of 608.03K.
- Price is -5.3% vs its 50-day average ($7.72) and -10.3% vs its 200-day average ($8.15).
- 52-week range $6.96–$10.23; today's close sits at 11% of that range, 28.5% below the 52-week high.
GRFS latest news & SEC filings
Every SEC filing by or about GRFS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Jul 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade GRFS
- How much it moves: over the last 20 sessions the average daily move was 1.26% (largest 4.1%).
- Liquidity: about 686.78K shares (≈$5.25M) trade per day on average.
- 52-week position: $7.64 vs a range of $6.96–$9.90 (23% of the range).
- Dividends: last ex-dividend date Jul 2, 2026 ($0.094/share); 1 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Jul 30, 2026; 6-K Jul 29, 2026; 6-K Jun 22, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
GRFS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.59 | 7.75 | 7.57 | 7.64 | 872.36K |
| Oct 15, 2026 | 7.51 | 7.56 | 7.40 | 7.54 | 907.10K |
| Oct 14, 2026 | 7.29 | 7.40 | 7.22 | 7.24 | 538.50K |
| Oct 13, 2026 | 7.36 | 7.36 | 7.15 | 7.17 | 439.50K |
| Oct 12, 2026 | 7.52 | 7.52 | 7.36 | 7.37 | 266.10K |
| Oct 9, 2026 | 7.51 | 7.53 | 7.44 | 7.46 | 330.60K |
| Oct 8, 2026 | 7.42 | 7.45 | 7.28 | 7.41 | 368.10K |
| Oct 7, 2026 | 7.48 | 7.56 | 7.44 | 7.50 | 260.70K |
| Oct 6, 2026 | 7.53 | 7.57 | 7.42 | 7.52 | 326.10K |
| Oct 5, 2026 | 7.31 | 7.54 | 7.29 | 7.41 | 492.80K |
| Oct 2, 2026 | 7.30 | 7.36 | 7.24 | 7.31 | 390.40K |
| Oct 1, 2026 | 7.29 | 7.33 | 7.20 | 7.30 | 623.10K |
| Sep 30, 2026 | 7.35 | 7.38 | 7.30 | 7.31 | 773.00K |
| Sep 29, 2026 | 7.40 | 7.42 | 7.24 | 7.30 | 485.00K |
| Sep 28, 2026 | 7.35 | 7.47 | 7.35 | 7.41 | 597.10K |
| Sep 25, 2026 | 7.36 | 7.39 | 7.29 | 7.35 | 507.20K |
| Sep 24, 2026 | 7.17 | 7.28 | 7.15 | 7.20 | 536.10K |
| Sep 23, 2026 | 7.33 | 7.38 | 7.19 | 7.20 | 4.07M |
| Sep 22, 2026 | 7.41 | 7.45 | 7.39 | 7.44 | 600.10K |
| Sep 21, 2026 | 7.34 | 7.39 | 7.33 | 7.36 | 356.70K |
About Grifols SA
Grifols SA (GRFS) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in NEW YORK, NY. Fiscal year ends —. SEC CIK 1438569.
GRFS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GRFS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
GRFS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GRFS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.